Over PAR, page-23

Is this perhaps all about an education process? PR and the crew of paid educators are earnestly bringing FDA minions up to speed -none of whom can either be individually identified or speculatively assumed to have true expertise in this the sharp inflamed end.As classic bureaucrats they put insignificant obstacles e.g. rats with esoteric and likely unrelated symptoms-in the way of enlightenment until they feel that the weight of evidence will protect their personal "cloaca Maxima" at the time they hand an affirmative decision to those that pat them on their head (and influence their income). In the meantime earnest endeavour continues.
Observers, such as Mozz, offer extraordinarily detailed and scientific educational enlightenment rarely observed on other sites to we the investor.
While the true believers and frustrated investors want to forcefully reeducate the bureaucrats-particularly when an application appears to have zero negative but major benefit-the more astute view of how the bureaucracy functions is revealing.is it not about the financial staying power of the supporting interests as to whether many drugs succeed or fail on the path regardless of their benefit .it seems (having been here since pre-float) that it's a long drawn out waiting game, extended by Covid, underestimated by many but nevertheless, provided we can financially sustain the education process, ultimately hugely successful.

So sit tight, buy or sell, be positive or negative but whichever way-it's your money-vote with your Wallet.